A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Our business is transforming healthcare by empowering the primary care physicians (“PCP”) to be the agents for change in the communities they serve. We believe that PCPs, with their intimate patient-physician relationships, are best positioned to drive meaningful change in quality, cost and patient experience when provided with the right infrastructure and payment model. Through our combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, we believe we are poised to revolutionize healthcare for seniors across communities throughout the United States (“U.S.”). We believe our purpose-built model provides the necessary capabilities, capital and business model for existing physician groups to create a Medicare-centric, globally capitated line of business.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 5.9B | 5.9B | 6.1B | 4.3B | 2.4B | 1.5B |
| Net Income | -391M | -391M | -260M | -263M | -107M | -406M |
| EPS | $-0.98 | $-0.98 | $-0.61 | $-0.48 | $-0.22 | $-1.03 |
| Free Cash Flow | -119M | -119M | -71M | -172M | -146M | -155M |
| ROIC | -5049.8% | -120.7% | -51.4% | -37.8% | -9.9% | -88.8% |
| Gross Margin | -0.8% | -0.8% | 3.6% | 7.1% | 12.3% | 0.0% |
| Debt/Equity | 0.43 | 0.43 | 0.07 | 0.06 | 0.05 | 0.05 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -463M | -463M | -292M | -232M | -105M | -372M |
| Operating Margin | -7.8% | -7.8% | -4.8% | -5.4% | -4.4% | -24.5% |
| ROE | -308.8% | -131.0% | -55.2% | -39.7% | -10.2% | -100.7% |
| Shares Outstanding | 399M | 399M | 426M | 547M | 484M | 395M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |||
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 794M | 1.2B | 1.5B | 2.4B | 4.3B | 6.1B | 5.9B | 5.9B |
| Gross Margin | 0.0% | 1.7% | 0.0% | 12.3% | 7.1% | 3.6% | -0.8% | -0.8% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 123M | 137M | 428M | 208M | 286M | 269M | 239M | 239M |
| EBIT | -107M | -57M | -372M | -105M | -232M | -292M | -463M | -463M |
| Op. Margin | -13.4% | -4.7% | -24.5% | -4.4% | -5.4% | -4.8% | -7.8% | -7.8% |
| Net Income | -283M | -60M | -406M | -107M | -263M | -260M | -391M | -391M |
| Net Margin | -35.6% | -4.9% | -26.7% | -4.5% | -6.1% | -4.3% | -6.6% | -6.6% |
| Non-Recurring | 0 | -20M | 473K | 0 | 0 | 3.6M | 36M | 36M |
| Returns on Capital | ||||||||
| ROIC | N/A | -12.7% | -88.8% | -9.9% | -37.8% | -51.4% | -120.7% | N/M |
| ROE | N/A | N/A | -100.7% | -10.2% | -39.7% | -55.2% | -131.0% | -308.8% |
| ROA | N/A | -27.1% | -40.0% | -6.3% | -15.1% | -15.0% | -26.0% | -30.8% |
| Cash Flow | ||||||||
| Op. Cash Flow | -104M | -53M | -148M | -131M | -156M | -58M | -106M | -106M |
| Free Cash Flow | -107M | -55M | -155M | -146M | -172M | -71M | -119M | -119M |
| Owner Earnings | -150M | -74M | -455M | -173M | -246M | -133M | -183M | -183M |
| CapEx | 2.9M | 1.8M | 6.6M | 15M | 16M | 13M | 13M | 13M |
| Maint. CapEx | 41M | 14M | 15M | 14M | 20M | 24M | 29M | 29M |
| Growth CapEx | 0 | 0 | 0 | 1.7M | 0 | 0 | 0 | 0 |
| D&A | 41M | 14M | 15M | 14M | 20M | 24M | 29M | 29M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 6.7M | 6.7M | 6.7M | 200M | 200M | 200M | 200M |
| Buyback Yield | N/A | N/A | N/A | N/A | 2.9% | N/A | N/A | 2.3% |
| Stock-Based Comp | 5.2M | 6.7M | 292M | 28M | 69M | 51M | 49M | 49M |
| Debt Repayment | 3.6M | 3.0M | 120M | 5.0M | 5.0M | 3.8M | 0 | 0 |
| Balance Sheet | ||||||||
| Net Debt | -139M | -34M | -984M | -882M | -177M | -342M | -293M | -119M |
| Cash & Equiv. | 139M | 107M | 1.0B | 465M | 108M | 188M | 174M | 174M |
| Long-Term Debt | 0 | 65M | 43M | 38M | 32M | 35M | 16M | 16M |
| Debt/Equity | 0.00 | -0.26 | 0.05 | 0.05 | 0.06 | 0.07 | 0.43 | 0.43 |
| Interest Coverage | -11.8 | -7.0 | -60.6 | -23.5 | -34.9 | -47.3 | -69.8 | -69.8 |
| Equity | -232M | -285M | 1.1B | 1.0B | 662M | 471M | 127M | 127M |
| Total Assets | -2.4M | 446M | 1.6B | 1.7B | 1.7B | 1.7B | 1.3B | 1.3B |
| Total Liabilities | 18M | 422M | 495M | 657M | 1.1B | 1.3B | 1.1B | 1.1B |
| Intangibles | N/A | 60M | 55M | 18M | 64M | 73M | 66M | 66M |
| Retained Earnings | N/A | -551M | -958M | -1.1B | -1.3B | -1.6B | -2.0B | -2.0B |
| Working Capital | N/A | 27M | 1.0B | 916M | 503M | 306M | 20M | 20M |
| Current Assets | N/A | 294M | 1.4B | 1.5B | 1.5B | 1.5B | 1.1B | 1.1B |
| Current Liabilities | N/A | 267M | 357M | 535M | 977M | 1.2B | 1.1B | 1.1B |
| Per Share Data | ||||||||
| EPS | -0.39 | -0.20 | -1.03 | -0.22 | -0.48 | -0.61 | -0.98 | -0.98 |
| Owner EPS | -0.21 | -0.25 | -1.15 | -0.36 | -0.45 | -0.31 | -0.46 | -0.46 |
| Book Value | -0.32 | -0.95 | 2.77 | 2.15 | 1.21 | 1.10 | 0.32 | 0.32 |
| Cash Flow/Share | -0.14 | -0.18 | -0.38 | -0.27 | -0.29 | -0.14 | -0.26 | -0.91 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 724.6M | 300.3M | 394.6M | 484.3M | 547.1M | 426.5M | 399.3M | 399.3M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -22.1 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | 9.6 | 7.4 | 10.4 | 1.7 | 2.3 | 68.2 |
| Price/Sales | N/A | N/A | 8.1 | 4.3 | 2.4 | 0.4 | 0.2 | 1.5 |
| FCF Yield | N/A | N/A | -1.5% | -1.9% | -2.5% | -8.8% | -41.0% | -1.4% |
| Market Cap | N/A | N/A | 10.5B | 7.7B | 6.9B | 810M | 290M | 8.6B |
| Avg. Price | N/A | N/A | 31.04 | 21.04 | 19.32 | 5.02 | 2.23 | 21.63 |
| Year-End Price | N/A | N/A | 26.67 | 15.99 | 12.53 | 1.90 | 0.73 | 21.63 |
agilon health, inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 4.5%. Total shareholder yield (buybacks) is 2.3%.
agilon health, inc. (AGL) has a 5-year average return on invested capital (ROIC) of -61.7%. This is below average and may indicate limited pricing power.
agilon health, inc. (AGL) has a market capitalization of $8.6B. It is classified as a mid-cap stock.
agilon health, inc. (AGL) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 2.32%.
agilon health, inc. (AGL) operates in the Services-Misc Health & Allied Services, Nec industry, within the Healthcare sector.
agilon health, inc. (AGL) reported annual revenue of $5.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
agilon health, inc. (AGL) has a net profit margin of -6.6%. The company is currently unprofitable.
agilon health, inc. (AGL) generated $-119 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
agilon health, inc. (AGL) has a debt-to-equity ratio of 0.43. This indicates a conservatively financed balance sheet.
agilon health, inc. (AGL) reported earnings per share (EPS) of $-0.98 in its most recent fiscal year.
agilon health, inc. (AGL) has a return on equity (ROE) of -131.0%. A negative ROE may indicate losses or negative equity.
agilon health, inc. (AGL) has a 5-year average gross margin of 4.5%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 7 years of financial data for agilon health, inc. (AGL), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
agilon health, inc. (AGL) has a book value per share of $0.32, based on its most recent annual SEC filing.